USPTO serial 74352964
ARIPROX
Reviewed by CopyMark Law Group
Status 605
- Filing date
- Status date
- Registration date
- —
- Examiner
- MICHELI, ANGELA M
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ARIPROX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
D-1000 Berlin 65, DE
D-1000 Berlin 65, DE
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceuticals; namely, an anti-cancer preparation used and dispensed in the treatment of breast cancer as part of a hospital based chemotherapy program supervised by an oncologist | ABANDONED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 22, 1994 | ABN5 | ABANDONMENT - AFTER PUBLICATION | — |
| Jul 13, 1993 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 12, 1993 | NPUB | NOTICE OF PUBLICATION | — |
| May 5, 1993 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 14, 1993 | DOCK | ASSIGNED TO EXAMINER | — |